Qnovia
Richmond, US · Delaware corporation · 3 known investors
Find your way into Qnovia
Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation. The company targets patients seeking nicotine replacement therapy in the pulmonary drug delivery and digital health space.
Founders & leadership
MD
Mario DanekinFounder
BQ
Brian QuigleyExecutive
Board
SF
Sean FaheyBoard director
BR
Brian RianoBoard director
GS
Investors · 3
Reported raises · per SEC filings
Form D private placements$41.3M disclosed across 3 rounds · 2022–2024
▶$14.2MraisedNov 2024 · 7 investors · PharmaceuticalsRule 506(b)
▶$14.2MraisedNov 2024 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mario DanekExecutive Officer, Director
- Sean FaheyDirector
- Brian QuigleyExecutive Officer, Director
- Brian RianoDirector
- Gregg SmithDirector
- Offering amount
- $16M
- Amount sold
- $14.2M
- Proceeds to insiders
- $1.6M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJun 2023 · 3 investors · BiotechnologyRule 506(b)
▶$2.9MraisedJun 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian RianoDirector
- Mario DanekExecutive Officer, Director
- Brian QuigleyExecutive Officer, Director
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $5M
- Amount sold
- $2.9M
- Proceeds to insiders
- $500K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedAug 2022 · BiotechnologyRule 506(b)
▶$24.2MraisedAug 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian QuigleyDirector
- Mario DanekDirector
- Gregg SmithDirector
- Sean FaheyDirector
- Offering amount
- $30M
- Amount sold
- $24.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA19 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Bioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Attovia Therapeutics10 shared keywordsAttovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options. Its team includes a leadership team, board of directors, and scientific advisors experienced in drug development and company building.
Companies competing with Qnovia for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structureQnoviaDelaware
In the news
Frequently asked questions
- What does Qnovia do?
- Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation. The company targets patients seeking nicotine replacement therapy in the pulmonary drug delivery and digital health space.
- Who founded Qnovia?
- Qnovia was founded by Mario Danek.
- Who are Qnovia's investors?
- Qnovia's investors include Evolution VC Partners, Blue Ledge Capital, Vice Ventures.
- How much funding has Qnovia raised?
- Qnovia has disclosed $41.3M raised across 3 rounds.
- Where is Qnovia headquartered?
- Qnovia is headquartered in Richmond, US.